UK and Ireland gas generator agreement
Claind, Italian manufacturer of gas generators has appointed Jaytee Biosciences as the sole distributor and service agent for their Brezza range of gas generators in the UK and Ireland.
Claind, Italian manufacturer of gas generators has appointed Jaytee Biosciences as the sole distributor and service agent for their Brezza range of gas generators in the UK and Ireland. The companies report that Jaytee will use their team of engineers to support, service and repair the range of nitrogen, hydrogen and air generator products.
“As an HPLC and GC specialist provider for over 35 years, Jaytee have the perfect skill set to service and support Claind customers throughout the British Isles. We look forward to applying our professionalism and quality service to a field that crosses over perfectly into our portfolio,” said John Tiley, Jaytee managing director.
Further to the agreement, Claind plan on establishing a global network of sales and service centres with partners around the world to distribute its products and guarantee after sales service to its customers.
For more information visit www.claind.it
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
